BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Delishaj D, Fumagalli IC, Ursino S, Cristaudo A, Colangelo F, Stefanelli A, Alghisi A, De Nobili G, D’Amico R, Cocchi A, Ardizzoia A, Soatti CP. Neoadjuvant radiotherapy dose escalation for locally advanced rectal cancers in the new era of radiotherapy: A review of literature. World J Clin Cases 2021; 9(30): 9077-9089 [PMID: 34786390 DOI: 10.12998/wjcc.v9.i30.9077]
URL: https://www.wjgnet.com/2307-8960/full/v9/i30/9077.htm
Number Citing Articles
1
Giuditta Chiloiro, Angela Romano, Davide Cusumano, Luca Boldrini, Giulia Panza, Lorenzo Placidi, Elisa Meldolesi, Matteo Nardini, Guenda Meffe, Gianluca Nicolini, Claudio Votta, Luca Indovina, Maria Antonietta Gambacorta. THeragnostic utilities for neoplastic DisEases of the rectum by MRI guided radiotherapy (THUNDER 2) phase II trial: interim safety analysisRadiation Oncology 2023; 18(1) doi: 10.1186/s13014-023-02353-x
2
Min Kyu Kang. Implications of recent neoadjuvant clinical trials on the future practice of radiotherapy in locally advanced rectal cancerWorld Journal of Gastroenterology 2023; 29(6): 1011-1025 doi: 10.3748/wjg.v29.i6.1011
3
Yuyan Xu, Haizhou Zou, Zhenyong Shao, Xuebang Zhang, XiaoLin Ren, Huijuan He, Dahai Zhang, Dexi Du, Changlin Zou. Efficacy and safety of different radiotherapy doses in neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: A retrospective studyFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1119323